Predictive Laboratories Announces its Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point-of-Care
ASSURANCE AB™ is a rapid test developed to detect the presence of IgM and/or IgG antibodies associated with the SARS-CoV-2 virus. ASSURANCE AB™ is a single-use, self-contained test that requires a small sample of the patient’s blood, collected via fingerstick. Results appear on testing device within 15 minutes. The results indicate the presence of antibodies, developed in response to the SARS-CoV-2 virus associated with the COVID-19 pandemic. The test will be available in all 50 states across the U.S. through Predictive’s distribution partner, Wellgistics.
See Newsroom for further announcements.